BusinessKite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional SharesBy Nasdaq OMXDec 11, 2015, 1:01 PM UTC
BusinessCytomX Selects Probody Drug Conjugate Clinical Candidate, CX-2009, Targeting Highly Expressed Tumor Antigen, CD166By Nasdaq OMXDec 11, 2015, 1:01 PM UTC
BusinessOtonomy Announces FDA Approval of OTIPRIO(TM) for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement SurgeryBy Nasdaq OMXDec 11, 2015, 12:31 PM UTC
BusinessGino Santini and Daniel Welch Elected to Board of Directors of Intercept PharmaceuticalsBy Nasdaq OMXDec 11, 2015, 12:06 PM UTC
BusinessCynapsus Therapeutics Announces Successful Completion of Bioavailability and Pharmacokinetic Study and Provides Update on European Clinical PlansBy Nasdaq OMXDec 10, 2015, 9:11 PM UTC
BusinessOhr Pharmaceutical Reports Fiscal Year 2015 Financial and Business ResultsBy Nasdaq OMXDec 10, 2015, 9:02 PM UTC
BusinessImmunomedics Reports Continuing Positive Results With Sacituzumab Govitecan in Heavily Pre-Treated Metastatic Triple-Negative Breast Cancer PatientsBy Nasdaq OMXDec 10, 2015, 1:31 PM UTC
BusinessOryzon Genomics Announces Listing on Madrid Stock ExchangeBy Nasdaq OMXDec 10, 2015, 1:16 PM UTC
